Publicaciones en las que colabora con Gema Fruhbeck Martínez (13)

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

2021

  1. Benefits of Bariatric Surgery Prior to SARS-CoV-2 Infection in Modulating the Response to COVID-19

    Obesity

  2. Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study

    European Journal of Internal Medicine, Vol. 91, pp. 3-9

2020

  1. Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery

    Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299

  2. Revisiting the Ghrelin Changes Following Bariatric and Metabolic Surgery

    Obesity Surgery, Vol. 30, Núm. 7, pp. 2763-2780

  3. Unravelling gender-specific factors that link obesity to albuminuria

    European Journal of Clinical Investigation, Vol. 50, Núm. 11

2019

  1. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk

    Nutrients, Vol. 11, Núm. 11

2017

  1. Eligibility and success criteria for bariatric/metabolic surgery

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 529-543

2016

  1. Cardiovascular prevention in obese patients

    Current Pharmaceutical Design, Vol. 22, Núm. 37, pp. 5687-5697

  2. Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery?

    Obesity Surgery, Vol. 26, Núm. 2, pp. 282-288

  3. Increased interleukin-32 levels in obesity promote adipose tissue inflammation and extracellular matrix remodeling: Effect of weight loss

    Diabetes, Vol. 65, Núm. 12, pp. 3636-3648

  4. Metabolic Surgery Enters the T2DM Treatment Algorithm

    Trends in Endocrinology and Metabolism

  5. Tratamiento quirúrgico de la obesidad: pros y contras

    Anales de la Real Academia Nacional de Farmacia, Vol. 82, Núm. 2, pp. 225-233